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Modulation of phospholipase A2 activity and sodium transport by
angiotensin-(1-7). Angiotensin II (Ang II) receptors are coupled to a
variety of signal transduction mechanisms. In the kidney, Ang II at
nanomolar concentration binds to proximal tubular cells and stimulates
phospholipase A2 (PLA2), which in turn catalyzes the hydrolysis of
phosphatidylcholine into lysophosphatidylcholine (LPC) and fatty acid.
This signal transduction pathway has been shown to be an important
modulator of sodium transport. The kidney cortex possesses the
enzyme necessary to convert angiotensin I (Ang I) directly to Ang-(1-7)
bypassing Mg II as an intermediate. The present investigation was
undertaken to determine whether Ang-(1-7) influences epithelial cell
function by comparing this heptapeptide with Ang II as a modulator of
PLA2 activity and sodium transport. Proximal tubular cells were
labeled in tissue culture with 3H-choline and PLA2 activity was mea-
sured by quantitation of LPC. We found that Ang II (l0 M to 10-6 M)
significantly increased PLA2 activity (154 36% to 209 94%). Similar
results were obtained with Ang-(1-7) (240 130% to 353 40%). The
bioactivity of the peptides was assayed by its ability to regulate
transcellular 22Na flux. Ang II (10—u M) inhibited 22Na flux by 12 2%
while Ang-(l-7) (l0— M) inhibited 22Na flux by 20 5%. These results
suggest that one potential role of Ang-(l-7) in the regulation of kidney
epithelial electrolyte transport may involve activation of PLA2.
Insights into the mechanisms by which the renin-angiotensin
system (RAS) participates in the regulation of blood pressure
have emerged with the discovery of specific inhibitors of the
angiotensin converting enzyme (ACE) and renin. The expres-
sion of genes for renin, ACE and angiotensinogen in organs
other than kidney [1] led to the hypothesis that in addition to the
influence of the circulating RAS, local synthesized angiotensin
may exert autocrine-paracnne influences on cellular function
within specific tissues [2—5]. Therefore, the tissue source of
angiotensin(s) might potentially mediate alterations in local
function independent of the circulating RAS. Within the kidney,
previous work suggests that the proximal tubule is a major site
of local angiotensin (Ang) generation [1]. In addition, the
proximal tubule is the site where Ang II receptors are abundant
on both the brush border and basolateral membranes [6-8].
Finally, significant microheterogeneity in Ang II receptor dis-
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tnbution exists in that the first millimeter of proximal tubule has
a 10-fold higher receptor density than the next 2 to 5 mm [9].
Thus, Ang II plays an important role as a modulator of sodium
and bicarbonate reabsorption [10—13].
It is believed that a major pathway for angiotensin I (Ang I)
formation is cleavage of angiotensinogen by the enzyme renin.
Subsequently, ACE acts on Ang Ito produce Ang II. Ang II is
further processed to Ang III and other smaller fragments, so far
without marked biological activity. Recently, alternative path-
ways for Ang I processing have been described in the CNS and
other tissues [14—16]. Ang-(1-7) can be generated from either
Ang I or Ang II by the enzyme neutral endopeptidase 24.11, and
directly influence cellular functions [16]. Of special interest is
the fact that the proximal tubule is an abundant source of
endopeptidase 24.11, thus raising the possibility that Ang-(1-7)
may also be generated within the kidney [16]. The present
studies investigate the influence of Ang-(1-7) and congener
peptides on phospholipase A2 activity, a signaling pathway
implicated in the regulation of sodium transport in proximal
tubular epithelium [12].
Methods
Cell isolation and culture
Two kg New Zealand white male rabbits were sacrificed
using a CO2 gas chamber and renal proximal tubules were
isolated as previously described [17]. Briefly, the kidneys were
aseptically removed and immediately placed in Collin's solu-
tion. Kidneys were perfused via the renal artery with 20 ml of
Collin's and 5% fetal calf serum followed by a second perfusion
of the same solution with 5 m EGTA. The kidney capsule was
removed in a sterile hood and cortical slices were placed on ice
for microdissection of proximal tubule segments. Glomeruli
were located and the first several mm of proximal tubule were
removed and placed on a Millicel-CM culture insert previously
coated with Ethicon. Tubules were allowed to attach to the
filters in a minimum volume of apical media. After several hours
500 pi of medium was added to the basolateral side. Primary
cultures were not disturbed for several days following initial
plating. The primary cultures were then fed with medium every
two to three days and kept at 37°C in 5% CO2 and 95% air.
In addition, proximal tubular cells were isolated by a Percoll
density gradient as previously described [17, 18] and grown to
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confluency in 75 cm2 flasks. Cell culture medium consisted of
Dulbecco's Modified Eagle's and Ham's F-12 media (1:1)
supplemented with 15 mrvi HEPES, 1.2 mg/mi NaHCO3, 192
lU/mi penicillin, 200 g/ml streptomycin, 50 nM hydrocortisone
and, 5% heat-inactivated fetal bovine serum. Second passage
proximal tubular cells grown to confluence on 12-well tissue
culture plates were used for PLA2 measurements. Microdis-
sected proximal tubules were used for ion transport experi-
ments when cells were confluent and conductance sufficiently
low, as previously described by this laboratory [18].
PLA2 assessment
Cells were washed and placed in 0.5% serum, choline-free
tissue culture media for 24 hours during labeling with 3H-
choline (1 CiIml). After 24 hours, cells were washed twice with
phosphate buffered saline (PBS) containing glucose (10 mM) and
0.2% BSA (37°C, pH 7.4). A single well was washed with pure
PBS (no glucose, no BSA) for protein determination [19]. The
experimental (Ang II and analogs) and control buffers were
added to individual wells and incubated for 30 minutes at 37°C.
Experiments were conducted in triplicate. The reaction was
stopped by adding 1.25 mIiwell ice cold methanol. Lipid extrac-
tion was conducted according to the methods described by
McKean, Smith and Silver [20]. Cells were scraped and trans-
ferred with a silinazed pipette to a 15 ml polypropylene tube
containing 1.25 ml chloroform. An equal volume of methanol
was added to the well, scraping was repeated, and well contents
transferred to the previous tube. Tubes were vortexed and
allowed to stand for 45 minutes. After this period, 1.25 ml of
both chloroform and distilled water were added to each tube
and centrifuged (2430 rpm/S mm). The organic layer was
transferred with a Pasteur pipette to glass tubes. Samples were
allowed to dry under a stream of nitrogen. Twenty-five micro-
liters of chloroform were added to each tube for spotting of
samples by thin layer chromatography (silica gel plates with
pre-absorbed strips, 19 channels). The sample was spotted in
four channels and chromatographed with an LPC standard in
methanol, chloroform, acetic acid and distilled water (50:30:7:
4). The plates were developed, dryed in air for 30 minutes, and
placed in a tank saturated in iodine vapor for visualization of the
phospholipids zones. LPC was quantitated by scraping lanes
followed by scintillation counting. Previous data from our
laboratory revealed that Ang 11-mediated PLA2 activation starts
at nanomolar concentrations of the peptide [12]. Therefore, the
peptides tested in this work are in a i0 to 10—6 M range.
Peptides included: Ang I, Ang II, Sar'-Ang II, Ang III-(2-8)
and, the heptapeptide Ang-(1-7). In the designated experiments,
cells were simultaneously incubated with either: Captopril [an
ACE inhibitor (10—6 M)] or [Sar'-Thr8]-Ang II [an Ang J
antagonist (10—6 M)].
22Na transport studies
Na transport was measured by unidirectional Na flux
(apical to basal) of 22Na across confluent monolayers of micro-
dissected proximal tubule on Millicell-CM culture inserts as
detailed elsewhere [18, 21]. Experiments were conducted in a
sterile culture incubator maintained at 37°C and 5% CO2. The
experimental solution was Dulbecco's Modified Eagle's Media
(DMEM) without phenol red plus 0.1% fatty acid free BSA.
22Na (400 nCi) was added to the apical chamber containing a
total apical volume of 350 jd. After peptide addition to the
apical side, the basal solution was removed every 10 minutes
and radioactivity counted. In order to have an accurate mea-
surement throughout the experiment, 10 p1 aliquots of the
apical solution were taken at each time point. Samples were
counted for 2.5 minutes in a gamma counter. Unidirectional
22Na flux (JNa; apical to basal) is calculated by the equation
[18]:
Na = ([Na1ap) (cPmbl
— cpmbg)/(cpmaplvolumeap)/(0.6 cm2)/10 mm
whereby: cpm = counts/mm and, the subscripts bl = basolat-
eral, bg = background, ap = apical.
Basal JNa was established by a 50-minute equilibration period
prior to peptide/drug addition. After adding the experimental
substance, JNa was measured for an additional 60 minutes.
Values after experimental addition were compared to the one
immediately preceding addition and expressed as percent
change.
Statistical analysis
Results are expressed as mean standard deviation, unless
otherwise stated. One-way analysis of variance was used to
analyze differences among peptide treatments at the same dose.
Student's t-test for paired (Na flux studies) and unpaired data
(Figs. 3 and 4) were also employed.
Results
Stimulation of phospholipase A2
In the kidney, as well as in other organs, phosphatidylcholine
(PC) is the most abundant phospholipid (34% of the total
phospholipid content [22, 23]). When activated, PLA2 catalyzes
the hydrolysis of the ester bond in position 2 of PC to form a
free fatty acid (usually arachidonic acid) and lysophosphatidyl-
choline (LPC). Thus, release of LPC following stimulation
correlates with PLA2 activation. Figure 1 illustrates the effects
of Ang II on LPC generation. In absolute value, maximal Ang II
stimulation of PLA2 activity was observed at 1 jiM (N = 6).
However, this result is not statistically different from the results
observed at higher or lower doses. The ED50 for LPC released
by Ang II was found to be 3.4 0.14 nM [181. Comparative
effects of Ang II analogs are shown in Figure 2. As demon-
strated in this figure, all angiotensin peptides were effective in
PLA2 activation. Of interest in this study is the equipotency of
Ang-(l-7) to Ang II on PLA2 activation. Statistical analysis of
the data revealed no significant difference between Ang II and
Ang-(1-7) at the doses tested. Ang I also has a reproducible
action on proximal tubular cells, however, higher doses were
needed for PLA2 activation when the decapeptide was used.
To demonstrate the specificity of Ang II action on LPC
production, the Ang II antagonist [Sar'-Thr8]-Ang II was ap-
plied simultaneously with Ang II. As shown in Figure 3, Ang II
(10_8 M) induced a 294 54% increase in LPC, whereas in the
presence of [Sar'-Thr8]-Ang 11(10—6 M), Ang 11(10—8 M and
10_6 M) increased LPC levels only by 140 13% and 218
21%, respectively. Equimolar doses of agonist and antagonist
when simultaneously applied were not statistically different
from the agonist action by itself (results not shown).
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FIg. 3. Angiotensin 11 (10 M and 10_a M) action on LPC synthesis
was quantitated in the absence or in the presence of the Ang 11
antagonist (Sar' ,Th/-Ang 11 (fIr6 hi) (N = 6). In the presence of the
antagonist, the decrease in LPC production correlates with the dose of
Mg!! employed. However, at equimolar doses, Ang U overcomes the
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Fig. 2. Comparative effects obtained upon Ang-(1-7) (U), Ang II (A)
and congener (•, Ang III; X, [Sar']-Ang II; +, Ang I) peptides on the
synthesis of LPC as described in Figure 1. Each peptide shown in this
figure was tested at least in three experiments. Each dose was tested at
least twice and at most four times, the average for each dose was taken
and compared to its respective control (total of six experiments).
One-way analysis of variance revealed no difference among peptides or
dosages tested. Standard deviation bars are omitted to avoid crowding
of the figure.
As the proximal tubule is one of the most abundant sources of
ACE, we sought to investigate the role of this enzyme on PLA2
activity stimulated by Ang I. In Figure 4, Ang I (l0— M) alone
increased LPC by 169 17%. However, when the same dose of
Ang I was added with Captopril (10—6 M) an increase of 250
65% was observed. This suggests that an alternative enzymatic
pathway is present for processing of Ang I. For example,
conversion of Ang I to Ang-(l-7) via an endopeptidase might
occur in the proximal tubular cells.
Modulation of sodium transport
The following experiments were conducted to evaluate the
biological action of Ang-(l-7). Primary confluent monolayers of
Fig. 4. Incubation of rabbit proximal tubular cells (N = 5) for 30
minutes with Ang I (10-i M) alone, or simultaneous incubation of Ang
I (10 M) and Captopril (10—6 si) reveals two different quantitative
responses on LPC synthesis. The observed potentiation of Ang I action
on LPC synthesis in the latter case is suggestive of an alternative
metabolic pathway for Ang I processing. < 0.05.
proximal tubular cells were grown in culture until a conduc-
tance of less than 20 mS/cm2 was achieved. Such monolayers
were polarized and formed a physiological barrier between
apical and basal compartments [21, 24], facilitating quantitation
of angiotensin-mediated transport. Our previous results and
those from other laboratories have demonstrated that apical
Ang II stimulates PLA2 and releases arachidonic acid, which is
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Fig. 1. Stimulation of PLA2 induced by Ang II in rabbit proximal
tubular cells labeled with 311-choline was measured through production
of lysophosphatidylcholine (LPC). Triplicate wells were incubated
during 30 mm with individual concentrations of Ang II or buffer alone
and LPC production was quantitated in a total of 6 experiments. In this
and subsequent figures, a control value based on the 3H counts obtained
with buffer solution alone is considered to be 100%. The results are
expressed as means SD. P < 0.001 for Ang II at all doses tested.
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Table 1. Sodium transport responses of proximal tubular cells
%
Change
Stimulus in Na N
Ang II 50 nM —12 2 13
Ang-(l-7) 1 nw —20 5 4
5,6EET2MM —11±5 7
Forskolin 100 sM —11 4 6
Ang 1110PM +25 4 25
Monolayers of microdissected rabbit proximal tubules were grown on
millicell-CM as described in Methods. Monolayers cultures with trans-
epithelial conductances less than 20 mS/cm2 were used for Na
transport measurements. Changes are expressed relative to a 50 mm
incubation time before addition of peptides or agents. Time 0 is defined
as time of addition. The baseline range of Na is from 0.007 to 0,2
tEq/minIcm2. The Na values for each monolayer time course are
normalized to the t = 50 mm point (last time point before peptide/drug
addition) by expressing data as % change JNa Values are taken from the
40 or 50 mm point after the addition of agonist and are represented as
mean SEM (P < 0.05 in all cases).
in turn metabolized via cytochrome P450-dependent epoxyge-
nase to 5,6 epoxy-eicosatrienoic acid (5,6 EET) [21, 24—27],
thereby influencing Na transport. This action of Ang II in the
flM to jsM range blocks JNa and is mimicked by the arachidonic
acid metabolite 5,6 EET (Table 1). Moreover, at nanomolar
dose Ang-(l-7) is equipotent with Ang II not only in stimulating
PLA2 but also in inhibiting JNa• Thus, the correlation between
a biochemical and a physiological response depicts the impor-
tant role that these peptides might have in the kidney. Activa-
tion of adenylyl cyclase with forskolin also has been shown to
inhibit JNa and mimic this PLA2-mediated effect on Na trans-
port [27].
Discussion
Observations presented in this report demonstrate that Ang-
(1-7) activates PLA2 and induces LPC release. The bioactivity
of the peptide was also evident since inhibition of sodium
transport was observed when proximal tubular cells are ex-
posed to Ang-(l-7). When Ang I was used to stimulate these
cells, a small but reproducible increment in LPC was observed.
The effects of Ang I have been suggested to be mediated by
conversion to Ang II and subsequent binding to Ang II recep-
tors since specific receptors for Ang I have never been de-
scribed. Furthermore, in the present report our results suggest
that Ang I may be metabolized to Ang-(l-7), since ACE
inhibition potentiates the ability of Ang Ito stimulate PLA2 to
levels observed with Ang II and Ang-(l-7). Ang-(1-7) synthe-
sized from Ang I during ACE inhibition could result in binding
of the heptapeptide to a specific receptor, thereby directly
stimulating PLA2 activity. We suggest that the blockade of
ACE permits production of Ang-(1-7) through an alternative
enzymatic pathway, namely endopeptidase 24.11. This enzyme
has been reported to be present in porcine proximal tubules
[16]. We suggest that such an enzyme or isoform(s) might be
present in the rabbit tubular epithelial cells contributing to the
observed effects of the angiotensins. Ang-(l-7) has been shown
to be generated independent of ACE in canine brain stem [14]
and other brain regions [28, 29] including proximal tubular cells
[16]. Because ACE inhibitors are also known to inhibit brady-
kinin degradation, one may argue that ACE inhibition could
induce a local bradykinin-evoked natriuretic response in these
cells mediated by PLA2 activation. However, kallikrein, the
enzyme responsible for local kinin production, is localized to
the distal tubule and collecting duct [30] but not proximally.
It has been recently reported that Ang receptors in tubules
and glomeruli within the kidney cortex are sensitive to both AT1
and AT2 angiotensin II receptor antagonists [31—33]. Binding to
AT1, but not AT2 receptor, is modulated by guanine nucleotides
[341. A further subclassification of Ang II receptors has been
proposed on the basis of interaction with selective antagonists.
For example, ATIB but not ATIA receptors are sensitive to
inhibition by PD 123319, whereas ATIA receptors are more
sensitive to losartan [35]. Both ATIA and AT18 are G-protein
coupled. In fact, Ang-(l-7) binds with high affinity to AT18 [351,
a site that comprises 14% of Ang II sites in glomerular me-
sangium and 40% of Ang II sites in proximal tubular epithelium
[32, 35]. Thus, it is possible that Ang-(1-7) binds to the ATIB site
on epithelial cells to mediate the effects on PLA2 and sodium
transport.
The effects of Ang II and its putative intracellular messengers
on sodium transport in this cellular system were previously
reported by Romero et a! [36] using a combination of electro-
physiology and measurement of JNa. It has been well estab-
lished that Ang II exerts a biphasic effect on proximal tubular
transport. Low concentrations stimulate Na and bicarbonate
reabsorption, while n concentrations and higher inhibit JNa
[10, 18]. Two signaling pathways mediate these responses,
namely, adenylyl cyclase inhibition and PLA2 stimulation,
respectively [12]. In the latter pathway, arachidonic acid is
metabolized to 5,6 EET via cytochrome P450-dependent epoxy-
genase. Ang-(l-7) was equipotent to Ang II in the inhibition of
1Na and mimicked the effects of forskolin and 5,6 EET.
Earlier studies conducted in this laboratory demonstrated
that kidney epithelial cells possess unique mechanisms of signal
transduction for Ang II. First, the peptide was unable to
hydrolyze phosphoinositides to inositol phosphates, specifically
1P3 [17]. Second, Ang 11-induced increments in intracellujar
calcium arise secondary to stimulation of PLA2, release of
arachdonic acid and metabolism to cytochrome P450-dependent
epoxygenase products such as 5,6 EET [36]. Third, arachdonic
acid and EETs open voltage-sensitive calcium channels and
thereby inhibit sodium transport [37]. As a result of these
observations, we conclude that Ang-(l-7) has a potential role in
the regulation of electrolyte transport in proximal tubular
epithelium, and that this phenomenon is likely to be mediated
through PLA2 activation.
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